Comparable clinical, endoscopic and histologic efficacy and tolerability of standard doses of ranitidine, omeprazole and pantoprazole in patients with gastro-oesophageal reflux disease (GORD)

Pulanić, Roland; Premužić, Marina; Brkić, Tomislav; Opačić, Milorad; Zorić, Vladimir; Curiš, Nada; Jokić-Begić, Nataša

Pregled bibliografske jedinice broj: 185315

Comparable clinical, endoscopic and histologic efficacy and tolerability of standard doses of ranitidine, omeprazole and pantoprazole in patients with gastro-oesophageal reflux disease (GORD)

Pulanić, Roland; Premužić, Marina; Brkić, Tomislav; Opačić, Milorad; Zorić, Vladimir; Curiš, Nada; Jokić-Begić, Nataša

Comparable clinical, endoscopic and histologic efficacy and tolerability of standard doses of ranitidine, omeprazole and pantoprazole in patients with gastro-oesophageal reflux disease (GORD), 2003. (ostalo).

CROSBI ID: 185315 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Comparable clinical, endoscopic and histologic efficacy and tolerability of standard doses of ranitidine, omeprazole and pantoprazole in patients with gastro-oesophageal reflux disease (GORD)

Autori
Pulanić, Roland ; Premužić, Marina ; Brkić, Tomislav ; Opačić, Milorad ; Zorić, Vladimir ; Curiš, Nada ; Jokić-Begić, Nataša

Izvornik
PosterView&#8482 ;

Vrsta, podvrsta
Ostale vrste radova, ostalo

Godina
2003

Ključne riječi
Gastroesophageal reflux disease; Therapy

Sažetak
The aim of this double-blind, controlled and randomised study was to compare efficacy and tolerability of the standard doses of ranitidine, omeprazole and pantoprazole. We concluded that pantoprazole is highly effective and well tolerated in the treatment of GORD

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA

Projekti:
0214209

Profili:

Roland Pulanić (autor)